NASDAQ : IMGN

ImmunoGen, Inc.

$31.235 USD

$0.01 (0.02%)

Volume
19.31M
Average Volume
9.19M
Market Capitalization
$8.73B
P/E Ratio
-35.54
Dividend Yield
0.00%
Price Target
$16.00
Year High
$31.25
Year Low
$3.61
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$2.26
IMGN Stock Grades
Date Grading Company Previous Grade New Grade Action
2023-12-04 Barclays Overweight Equal Weight Downgrade
2023-12-04 Piper Sandler Overweight Neutral Downgrade
2023-12-01 BMO Capital Outperform Market Perform Downgrade
2023-12-01 Barclays Overweight Equal Weight Downgrade
2023-12-01 Guggenheim Buy Neutral Downgrade
2023-12-01 Jefferies Buy Hold Downgrade
2023-11-30 HC Wainwright & Co. Buy Neutral Downgrade
2023-11-03 HC Wainwright & Co. Buy Buy Maintain
2023-09-13 JP Morgan Neutral Overweight Upgrade
2023-09-12 JP Morgan Neutral Overweight Upgrade
2023-08-29 HC Wainwright & Co. Buy Buy Maintain
2023-08-28 HC Wainwright & Co. Buy Buy Maintain
2023-08-02 Barclays Overweight Overweight Maintain
2023-08-01 Canaccord Genuity Buy Buy Maintain
2023-08-01 HC Wainwright & Co. Buy Buy Maintain
2023-08-01 Barclays Overweight Overweight Maintain
2023-08-01 BMO Capital Outperform Outperform Maintain
2023-07-31 BMO Capital Outperform Outperform Maintain
2023-07-31 HC Wainwright & Co. Buy Buy Maintain
2023-07-31 Canaccord Genuity Buy Buy Maintain
2023-06-13 HC Wainwright & Co. Buy Buy Maintain
2023-06-12 Barclays Overweight Overweight Maintain
2023-06-12 HC Wainwright & Co. Buy Buy Maintain
2023-06-12 Canaccord Genuity Buy Buy Maintain
2023-06-11 Barclays Overweight Overweight Maintain
2023-06-11 Canaccord Genuity Buy Buy Maintain
2023-06-06 Truist Securities Buy Buy Maintain
2023-06-05 Truist Securities Buy Buy Maintain
2023-06-05 Canaccord Genuity Buy Buy Maintain
2023-06-04 Canaccord Genuity Buy Buy Maintain
2023-05-03 Piper Sandler Neutral Overweight Upgrade
2023-05-02 Piper Sandler Neutral Overweight Upgrade
2023-05-01 HC Wainwright & Co. Buy Buy Maintain
2023-03-02 HC Wainwright & Co. Buy Buy Maintain
2023-01-23 JP Morgan Neutral Neutral Maintain
2023-01-22 JP Morgan Neutral Neutral Maintain